HHS - 144K Reasons To Be Bullish On Harte-Hanks Stock | Benzinga
A significant insider buy by Bradley Radoff, Board Member at Harte-Hanks (NASDAQ:HHS), was executed on December 5, and reported in the recent SEC filing.
What Happened: Radoff's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, involves purchasing 20,000 shares of Harte-Hanks. The total transaction value is $144,670.
In the Wednesday's morning session, Harte-Hanks's shares are currently trading at $6.91, experiencing a down of 6.62%.
About Harte-Hanks
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has its geographic presence in United States and Other countries. Majority of the revenue is earned from United States.
Key Indicators: Harte-Hanks's Financial Health
Revenue Growth: Harte-Hanks's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2023, the company experienced a revenue decline of approximately -12.56%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.
Key ...